Institut Gustave Roussy

EU Legislative Interests

Main European Strategies and funding programmes of interest as of November 2025: - European Beating Cancer Plan (EBCP) - European Code against Cancer - European Digital Strategy - European Green Deal - Pharmaceutical Strategy for Europe - Mission on Cancer Implementation Plan - Horizon Europe Work Programme - European Innovation Council (EIC) Work Programme - Marie Sklowdowska Curie (MSCA) Work Programme - European Research Council (ERC) Work Programme - Innovative Health Iniatives (IHI) Work Programme - EU4Health Work Programme - European Health Data Space (EHDS) Main EU regulations, directives and recommandations followed as of November 2025 - Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011/24/EU (Text with EEA relevance) - Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC - Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU - Regulation (EU) 2016/679 of the European parliament and of the council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) - Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence and amending Regulations (EC) No 300/2008, (EU) No 167/2013, (EU) No 168/2013, (EU) 2018/858, (EU) 2018/1139 and (EU) 2019/2144 and Directives 2014/90/EU, (EU) 2016/797 and (EU) 2020/1828 (Artificial Intelligence Act) - Regulation (EU) 2024/1938 of the European Parliament and of the Council of 13 June 2024 on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC - Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes - Council Recommandations on cancer screening in the EU - Council Conclusions on Reducing the Burden of Cancer - EU Parliament resolution on Combating Cancer in the EU - Ethical principles stated in the Declaration of Helsinki 1964, as revised in Fortaleza, 2013 - Good Clinical Practices guidelines (International Conference on Harmonization ICH E6), Statistical Principles for Clinical Trials (ICH E9), Clinical Safety Data Management guidance (ICH E2A)

Communication Activities

- Scientific publications and consensus recommandations from european scientific societies leading to revision of clinical practices guidelines and management of patients with cancer. - Coordination and participation as beneficiary in european funded projects and joint initiatives.

Interests Represented

Does not represent commercial interests

Member Of

Gustave Roussy is member of the following associations and networks : - Unicancer, the french federation of comprehensive cancer centers - Paris Saclay Cancer Cluster - Groupement d'Intérêt Public CANCEROPOLE IDF - Groupement de Coopération Sanitaire (GCS) Centre International des Cancers Thoraciques - GCS SEQUOIA - GCS de cancérologie de Corse-du-Sud - IHU PRISM, the national cancer center on precision medicine on oncology - Paris Kids Cancer - Cancer Core Europe - Innovative Therapies for Children and Adolescents with Cancer - Organisation of European Cancer Institutes - European Research Network PAEDCAN

Organisation Members

N/A

Additional Information

Gustave Roussy accounts for 2025 are being finalized and information will be updated as soon as possible. No other contribution received exceeds 10% of the total budget.